Login
$ALUR
$0.67 +$0.00 (0.0%) Close

$ALUR 8-K SEC Filings

Filed On Filing
24 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

On August 17, 2026, Krishna Gupta, a Class I member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora...

24 Jul 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more

This letter agreement (the “Agreement”) confirms the agreement of Allurion Technologies, Inc., a Delaware corporation (the “Company”), and the holders of the Common Stock listed on Schedule I attached hereto (the “Stockholders”), pursuan...

23 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 17, 2026, Shantanu K. Gaur, M.D. notified Allurion Technologies, Inc. (the “Company”) of his resignation as Chief Executive Officer of the Company and as a member of the Company's board of directors (the “Board”), in each case ef...

07 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corpora...

30 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation

On June 24, 2026, R. Jason Richey, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and his role as the chairperson of the Au...

17 Jun 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

ALLURION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows:

27 May 2026 8-K: Changes in Registrant's Certifying Accountant

We have read Item 4.01 of Allurion Technologies, Inc.'s Form 8-K dated May 27, 2026, and have the following comments:

12 Mar 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events

Files appeal to NYSE on decision to initiate delisting proceedings

02 Mar 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events

Allurion Intends to Appeal NYSE Notice of Delisting While Executing Plan to Regain Compliance and Expects to Remain Trading

25 Feb 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN...

23 Feb 2026 8-K: Regulation FD Disclosure

Approval provides Allurion with access to approximately 80 million Americans with obesity

12 Jan 2026 8-K: Results of Operations and Financial Condition

Strong quarter-over-quarter revenue growth with continued, substantial improvement in operating expenses and operating loss

19 Dec 2025 8-K: Submission of Matters to a Vote of Security Holders

On December 18, 2025, Allurion Technologies, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to consider and vote on the seven proposals set forth below, each of which is described in detail in th...

12 Nov 2025 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more

This Securities Purchase Agreement (this “Agreement”) is dated as of November 11, 2025, between Allurion Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, inclu...

03 Oct 2025 8-K: Departure/Election of Directors or Officers; Compensation

On September 30, 2025, Milena Alberti-Perez, a Class III member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of her resignation from the Board and her role as the chairperso...

14 Aug 2025 8-K: Non-Reliance on Previously Issued Financial Statements

On August 14, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of Allurion Technologies, Inc. (the “Company”) concluded that certain of the Company’s previously issued financial statements, as described below, ...

13 Aug 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

NATICK, Mass. – August 13, 2025 – Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the second quarter and provided a business update.

07 Aug 2025 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +1 more

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

14 May 2025 8-K: Results of Operations and Financial Condition

NATICK, Mass.—May 14, 2025 — (BUSINESS WIRE) — Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a pioneer in metabolically healthy weight loss, today announced its financial results for the first quarter and provid...

17 Apr 2025 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities

This Second Amendment to Note Purchase Agreement (this “Amendment”), dated as of April 15, 2025, is among Allurion Technologies, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Company”), the purcha...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support